Results 91 to 100 of about 1,124,223 (245)

Loan Record of Geneva Cornell, April 17, 1903 [PDF]

open access: yes, 1903
Paper containing records of Geneva Cornell\u27s loan to Roy and Holly Cornell and the repayment terms, starting in 1903 and ending in 1926.https://digitalcommons.otterbein.edu/cornell_ephemera/1135/thumbnail ...
Cornell, Geneva
core  

Driving continuous improvement of sustainability certification for industrial biobased systems through comprehensive sustainability requirements

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Existing monitoring frameworks for sustainability certification schemes and labels (CSLs) have largely prioritised environmental aspects, while the social and economic pillars of sustainability remain comparatively underdeveloped. Also, dedicated circularity requirements tailored to biobased systems are still largely lacking, despite being ...
Iris Vural Gursel   +5 more
wiley   +1 more source

Improving Childhood Immunization Service Delivery in Cameroon: A Synthesis of Caregiver Experiences and Recommendations

open access: yesVaccines
Background/Objectives: A “people-centered” approach is one of the core principles of the Immunization Agenda (IA) 2030 and emphasizes the need for services to be organized around the needs and expectations of individuals and the community.
Yauba Saidu   +13 more
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Creating Enforceable Biosecurity Standards for Nucleic Acid Providers

open access: yesEngineering Biology
Although there is broad agreement among biosecurity experts that nucleic acid synthesis providers should screen orders for potential threats, there is no agreed upon mechanism to verify whether a provider is implementing effective screening practices ...
Jacob Beal, Tessa Alexanian
doaj   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens

open access: yesiScience
Summary: Direct acting antivirals (DAAs) represent critical tools for combating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) that have escaped vaccine-elicited spike-based immunity and future coronaviruses with ...
Irfan Ullah   +13 more
doaj   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola   +5 more
wiley   +1 more source

At the cusp of change: Agenda Setting in Global Health Law by Emerging Economies

open access: yesAJIL Unbound
Global health law as a field has been deeply unequal, reflecting colonial histories, geopolitics, and power plays. The current turmoil and fundamental shifts occurring in international politics has uncertain outcomes for global public health.
Priti Patnaik
doaj   +1 more source

Precision medicine in paediatrics: Progress and priorities

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Precision medicine is revolutionizing personalized healthcare, advancing both diagnostics and therapeutics at an unprecedented pace. Reviewing the paediatric applications of pharmacometrics, pharmacogenomics and advanced therapy medicinal products highlights not only the relevance of these exciting innovations to frontline care but also the significant
Nicola Husain   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy